Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

被引:549
|
作者
Wing, James B. [1 ]
Tanaka, Atsushi [1 ]
Sakaguchi, Shimon [1 ,2 ]
机构
[1] Osaka Univ, Immunol Frontier Res Ctr, Lab Expt Immunol, Suita, Osaka 5650871, Japan
[2] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan
关键词
TUMOR-INFILTRATING LYMPHOCYTES; IMMUNE DYSREGULATION; SELF-TOLERANCE; SUPPRESSIVE FUNCTION; EPIGENETIC CHANGES; FAMILY-MEMBER; CIS-ELEMENT; TREG CELLS; EXPRESSION; RECEPTOR;
D O I
10.1016/j.immuni.2019.01.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T (Treg) cells expressing the transcription factor Foxp3 have a critical role in the maintenance of immune homeostasis and prevention of autoimmunity. Recent advances in single cell analyses have revealed a range of Treg cell activation and differentiation states in different human pathologies. Here we review recent progress in the understanding of human Treg cell heterogeneity and function. We discuss these findings within the context of concepts in Treg cell development and function derived from preclinical models and insight from approaches targeting Treg cells in clinical settings. Distinguishing functional Treg cells from other T cells and understanding the context-dependent function(s) of different Treg subsets will be crucial to the development of strategies toward the selective therapeutic manipulation of Treg cells in autoimmunity and cancer.
引用
收藏
页码:302 / 316
页数:15
相关论文
共 50 条
  • [1] Human FOXP3+ T regulatory cell heterogeneity
    Mohr, Audrey
    Malhotra, Rajneesh
    Mayer, Gaell
    Gorochov, Guy
    Miyara, Makoto
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2018, 7 (01):
  • [2] Current trends with FOXP3+ regulatory T cell immunotherapy to contest autoimmunity and inflammation
    Trinath, Jamma
    Bayry, Jagadeesh
    IMMUNOTHERAPY, 2019, 11 (09) : 755 - 758
  • [3] The human FOXP3+ regulatory T cell population:: Single-cell study reveals a functional heterogeneity
    d'Hennezel, Eva
    Piccirillo, Ciriaco
    CLINICAL IMMUNOLOGY, 2008, 127 : S116 - S117
  • [4] Development and function of Foxp3+ regulatory T cells
    Wang, Yuan Min
    Ghali, Joanna
    Zhang, Geoff Yu
    Hu, Min
    Wang, Ya
    Sawyer, Andrew
    Zhou, Jimmy Jianheng
    Hapudeniya, Dhanushka A.
    Wang, Yiping
    Cao, Qi
    Zheng, Guoping
    Harris, David C.
    Alexander, Stephen I.
    NEPHROLOGY, 2016, 21 (02) : 81 - 85
  • [5] Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients
    Liu, Fangfang
    Li, Yaqing
    Ren, Meijing
    Zhang, Xinmin
    Guo, Xiaojing
    Lang, Ronggang
    Gu, Feng
    Fu, Li
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (02) : 459 - 467
  • [6] Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients
    Fangfang Liu
    Yaqing Li
    Meijing Ren
    Xinmin Zhang
    Xiaojing Guo
    Ronggang Lang
    Feng Gu
    Li Fu
    Breast Cancer Research and Treatment, 2012, 135 : 459 - 467
  • [7] Nature and nurture in Foxp3+ regulatory T cell development, stability, and function
    Geiger, Terrence L.
    Tauro, Sharyn
    HUMAN IMMUNOLOGY, 2012, 73 (03) : 232 - 239
  • [8] Restoration of established systemic inflammation and autoimmunity by Foxp3+ regulatory T cells
    Sharma, Varun Kumar
    Bayry, Jagadeesh
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (02) : 133 - 135
  • [9] Restoration of established systemic inflammation and autoimmunity by Foxp3+ regulatory T cells
    Varun Kumar Sharma
    Jagadeesh Bayry
    Cellular & Molecular Immunology, 2022, 19 : 133 - 135
  • [10] In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
    Christoph Loddenkemper
    Martin Schernus
    Michel Noutsias
    Harald Stein
    Eckhard Thiel
    Dirk Nagorsen
    Journal of Translational Medicine, 4